Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma 330Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Lymphoma, Large B-Cell, Diffuse 213Lymphoma, Non-Hodgkin 194Lymphoma, Follicular 168Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 124Hodgkin Disease 111Leukemia 103Recurrence 101Lymphoma, Mantle-Cell 88Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 57Multiple Myeloma 54Lymphoma, Extranodal NK-T-Cell 54Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Neoplasms 39Leukemia, B-Cell 39Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Lymphoma, Large-Cell, Anaplastic 24Hematologic Neoplasms 24Waldenstrom Macroglobulinemia 23Neoplasms, Plasma Cell 23Mycosis Fungoides 23Immunoblastic Lymphadenopathy 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pathologic Processes × Lymphoid × Clear all
NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

AO GENERIUM

Phase 1/2 Unknown
36 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡